Future Oncology · 2020 · 11 citations · 23 references
MedicineOncologySurgeryChemotherapyGastrointestinal OncologySurgical OncologyEndocrine Tumor PrognosisEndocrine TumorsEndoscopic Tumor ResectionGastric CancerNeuroendocrine Tumor SurgeryNeuroendocrine TumorsEndoscopic Cancer ResectionGastric Neuroendocrine NeoplasmsGastric Neuroendocrine Tumor ResectionInvasive Potential AssessmentKi-67 Labeling IndexNeuroendocrine Tumor ClassificationNeuroendocrine Tumor GradingTumor Stage Prognosis
Aim: The effects of different types of gastric neuroendocrine tumors (G-NETs) on treatment strategy formulation and prognostic evaluation still remain controversial due to their rarity. Methods: 187 patients diagnosed with G-NETs were subdivided into four types based on the pathophysiology, etiology and presentation. Results: Type I, II G-NETs >1.0 cm and type III, IV G-NETs >2.0 cm are proved with aggressive behavior (p < 0.05). Type III G-NETs with higher Ki-67 index and tumor stage showed more invasive potential than type I and II G-NETs (p < 0.05). Endoscopic resection is the primary treatment for type I, II G-NETs, while surgical combined with chemotherapy is associated with favorable outcomes for type IV G-NETs. Conclusion: The clinical classifications of G-NETs are of great significance for the choice of treatment and the evaluation of prognosis.
23
Mahul B. Amin, Frederick L. Greene, Stephen B. Edge et al. · CA A Cancer Journal for Clinicians · 2017 · 6.5K citations · Full text
Medicine, Cancer Biology, Oncology +17
Guido Rindi, David S. Klimstra, Behnoush Abedi‐Ardekani et al. · Modern Pathology · 2018 · 1.1K citations · Full text
Marc J. Berna, Bruno Annibale, Massimo Marignani et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 154 citations · Full text
Medicine, Endocrinology, Oncology +17